Caixin
Jan 05, 2022 08:13 PM
CHINA

Hong Kong Vaccine Surge Sees Majority Pick Sinovac Over BioNTech

A community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong, on Jan. 4. Photo: Bloomberg
A community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong, on Jan. 4. Photo: Bloomberg

(Bloomberg) — More Hong Kong residents are getting their first Covid-19 vaccinations, though the majority are receiving a Chinese immunization that studies have shown gives inadequate protection against the recently arrived omicron strain.

The city administered about 18,000 initial injections on Tuesday, the most in four months, as the highly-transmissible variant began spreading in the community and a looming expansion of the vaccine mandate led many people to fear losing access to restaurants and leisure facilities. The jump in first doses outpaced the roughly 16,400 booster shots given.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code